Sari Nakao

578 citations
18 papers · 441 indexed · h-index 11
Topics
Cervical Cancer and HPV Research (6 papers)Ovarian cancer diagnosis and treatment (6 papers)Venous Thromboembolism Diagnosis and Management (4 papers)
Partner nations
Japan

In The Last Decade

Sari Nakao

16 papers receiving 433 citations

Peers

Sari Nakao
Comparison fields: 5 of 54
  • Epidemiology 225
  • Surgery 99
  • Obstetrics and Gynecology 98
  • Cancer Research 86
  • Oncology 85
Replace Nobutaka Tasaka with:
Nobutaka Tasaka Japan
Azusa Akiyama Japan
Chang‐Yao Hsieh Taiwan
I. D. Duncan United Kingdom
C Natter Austria
Hayato Yamauchi Japan
Lorena Marimón Spain
Ho Sun Choi South Korea
J Rahhal Austria
Chanchal Sur Chowdhury United States
Sari Nakao relative to Nobutaka Tasaka Japan Nobutaka Tasaka's profile →
Citations per field
00.5×10×20×32×
Nobutaka Tasaka · 1×
Citations per year

Countries citing papers authored by Sari Nakao

Since Specialization
Citations

This map shows the geographic impact of Sari Nakao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari Nakao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari Nakao more than expected).

Fields of papers citing papers by Sari Nakao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sari Nakao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari Nakao. The network helps show where Sari Nakao may publish in the future.

Co-authorship network of co-authors of Sari Nakao

This figure shows the co-authorship network connecting the top 25 collaborators of Sari Nakao. A scholar is included among the top collaborators of Sari Nakao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari Nakao. Sari Nakao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 1
2 3
3 1
4 7
5 4
6 14
7 18
8
Paraneoplastic thrombocytosis as a prognostic marker in ovarian cancer
0
9 28
10 0
11 55
12 32
13 36
14 32
15 26
16 38
17 35
18 111

About Sari Nakao

Sari Nakao is a scholar working on Internal Medicine, Reproductive Medicine and Obstetrics and Gynecology, having authored 18 papers that have together received 441 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). The work is most often cited by research in Internal Medicine (70 citations), Obstetrics and Gynecology (98 citations) and Reproductive Medicine (69 citations). Sari Nakao has collaborated with scholars based in Japan. Frequent co-authors include Takeo Minaguchi, Toyomi Satoh, Koji Matsumoto, Hiroyuki Yoshikawa, Hiroyuki Ochi, Mamiko Onuki, M Sakurai, Akinori Oki, Satoshi Okada and Hiromi Hamada. Their work appears in journals such as PLoS ONE, British Journal of Cancer and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026